Treatment of Aggressive Localized Lymphoma
Prospective and multicentric Phase III study, evaluation of the interest of the radiotherapy after 4 or 6 cycles of CHOP 14 R regimen of chemotherapy , patients with agressive and localized B lymphoma , age 18 to 75 years.
B Cell Lymphoma
DRUG: rituximab|DRUG: doxorubicin|DRUG: vincristine|DRUG: prednisone|PROCEDURE: radiotherapy
Event Free Survival (EFS) and Progression Free Survival (PFS), EFS PFS one year after treatment
Pet-scan, pronostic impact of Pet-scan|radiotherapy, Toxicity of the radiotherapy
CHOP 14 R regimen of chemotherapy is a good standard in the treatment of agressive and localized B lymphoma.

Interest of the radiotheraphy